Diabetes medications found to influence cancer growth in unexpected ways What if the drugs millions take for diabetes every ...
The intricate link between endocrine disorders and cancer development has drawn significant interest, revealing how ...
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may affect cancer growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback